ABN AMRO economists Rogier Quaedvlieg, Arjen van Dijkhuizen and Bill Diviney note that China is a key beneficiary of the US Supreme Court ruling, as IEEPA-based reciprocal and fentanyl tariffs are scrapped and likely replaced by a lower 15% Section 122 rate.